Linagliptin And Glimepiride Compared In Type Two Diabetes
Sulfonylureas are often added to metformin to improve glycemic control, but at the known risk of increasing hypoglycemia and weight gain. In a report published in the Lancet, more than 1,500 patients...
View ArticleFDA Investigating Heart Failure Risk Linked To Onglyza
The FDA said today that it was conducting an investigation of a possible increased risk for heart failure associated with the diabetes drug saxagliptin. Saxagliptin is marketed by AstraZeneca as...
View Article
More Pages to Explore .....